FAK mediates the activation of cardiac fibroblasts induced by mechanical stress through regulation of the mTOR complex

Cardiovasc Res. 2010 Jun 1;86(3):421-31. doi: 10.1093/cvr/cvp416. Epub 2009 Dec 28.

Abstract

Aims: Cardiac fibroblasts are activated by mechanical stress, but the underlying mechanisms involved remain poorly understood. In this study, we investigated whether focal adhesion kinase (FAK) plays a role in the activation of cardiac fibroblasts in response to cyclic stretch.

Methods and results: Neonatal (NF-P3/80--third passage, 80% confluence) and adult (AF-P1/80--first passage, 80% confluence) rat cardiac fibroblasts were exposed to cyclic stretch (biaxial, 1 Hz), which enhanced FAK phosphorylation at Tyr397. Proliferation (anti-5-bromo-2'-deoxyuridine and anti-Ki67 nuclear labelling), differentiation into myofibroblasts (expression of alpha-smooth muscle actin--alpha-SMA), and the activity of matrix metalloproteinase-2 were equally enhanced in stretched NF-P3/80 and AF-P1/80. Treatment with the integrin inhibitor RGD peptide impaired FAK phosphorylation and increased apoptosis (TUNEL) in non-stretched and stretched NF-P3/80, whereas FAK silencing induced by small interfering RNA modestly enhanced apoptosis only in stretched cells. RGD peptide or FAK silencing suppressed the activation of NF-P3/80 invoked by cyclic stretch. In addition, NF-P3/80 depleted of FAK were defective in AKT Ser473, TSC-2 Thr1462, and S6 kinase Thr389 phosphorylation induced by cyclic stretch. The activation of NF-P3/80 invoked by cyclic stretch was prevented by pre-treatment with the mammalian target of rapamycin (mTOR) inhibitor rapamycin, whereas supplementation with the amino acid, leucine, activated S6K and rescued the stretch-induced activation of NF-P3/80 depleted of FAK.

Conclusions: These findings demonstrate a critical role for the mTOR complex, downstream from FAK, in mediating the activation of cardiac fibroblasts in response to mechanical stress.

Publication types

  • Research Support, Non-U.S. Gov't
  • Retracted Publication

MeSH terms

  • Actins / metabolism
  • Animals
  • Animals, Newborn
  • Apoptosis
  • Cell Differentiation
  • Cell Proliferation
  • Cells, Cultured
  • Collagen Type I / metabolism
  • Enzyme Activation
  • Fibroblasts / drug effects
  • Fibroblasts / enzymology*
  • Focal Adhesion Kinase 1 / genetics
  • Focal Adhesion Kinase 1 / metabolism*
  • Intracellular Signaling Peptides and Proteins / antagonists & inhibitors
  • Intracellular Signaling Peptides and Proteins / metabolism*
  • Leucine / metabolism
  • Matrix Metalloproteinase 2 / metabolism
  • Mechanotransduction, Cellular* / drug effects
  • Myocardium / cytology
  • Myocardium / enzymology*
  • Oligopeptides / pharmacology
  • Phosphorylation
  • Protein Serine-Threonine Kinases / antagonists & inhibitors
  • Protein Serine-Threonine Kinases / metabolism*
  • Proto-Oncogene Proteins c-akt / metabolism
  • RNA Interference
  • Rats
  • Rats, Wistar
  • Ribosomal Protein S6 Kinases / metabolism
  • Serine
  • Sirolimus / pharmacology
  • Stress, Mechanical
  • TOR Serine-Threonine Kinases
  • Threonine
  • Time Factors
  • Tuberous Sclerosis Complex 2 Protein
  • Tumor Suppressor Proteins / metabolism
  • Tyrosine

Substances

  • Actins
  • Collagen Type I
  • Intracellular Signaling Peptides and Proteins
  • Oligopeptides
  • Tuberous Sclerosis Complex 2 Protein
  • Tumor Suppressor Proteins
  • smooth muscle actin, rat
  • Threonine
  • Tyrosine
  • Serine
  • arginyl-glycyl-aspartic acid
  • mTOR protein, mouse
  • mTOR protein, rat
  • Focal Adhesion Kinase 1
  • Ptk2 protein, rat
  • Protein Serine-Threonine Kinases
  • Proto-Oncogene Proteins c-akt
  • Ribosomal Protein S6 Kinases
  • TOR Serine-Threonine Kinases
  • Matrix Metalloproteinase 2
  • Mmp2 protein, mouse
  • Leucine
  • Sirolimus